Michail Ignatiadis
Michail Ignatiadis
Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles
Verified email at bordet.be
Cited by
Cited by
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10 (4), 1-11, 2008
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The lancet oncology 15 (4), 406-414, 2014
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751-759, 2015
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling
HA Azim, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ...
Clinical cancer research 18 (5), 1341-1351, 2012
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
KS Saini, S Loi, E de Azambuja, O Metzger-Filho, ML Saini, M Ignatiadis, ...
Cancer treatment reviews 39 (8), 935-946, 2013
Different prognostic value of cytokeratin-19 mrna–positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
M Ignatiadis, N Xenidis, M Perraki, S Apostolaki, E Politaki, M Kafousi, ...
Journal of clinical oncology 25 (33), 5194-5202, 2007
Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility
M Ignatiadis, M Lee, SS Jeffrey
Clinical Cancer Research 21 (21), 4786-4800, 2015
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer
N Xenidis, M Ignatiadis, S Apostolaki, M Perraki, K Kalbakis, S Agelaki, ...
Journal of Clinical Oncology 27 (13), 2177-2184, 2009
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early …
M Ignatiadis, G Kallergi, M Ntoulia, M Perraki, S Apostolaki, M Kafousi, ...
Clinical Cancer Research 14 (9), 2593-2600, 2008
Assessing tumor infiltrating lymphocytes in solid tumors: A practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235, 2017
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
FC Bidard, T Fehm, M Ignatiadis, JB Smerage, C Alix-Panabières, ...
Cancer and Metastasis Reviews 32 (1), 179-188, 2013
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ...
PloS one 6 (6), e20980, 2011
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
DJ McBride, AK Orpana, C Sotiriou, H Joensuu, PJ Stephens, LJ Mudie, ...
Genes, Chromosomes and Cancer 49 (11), 1062-1069, 2010
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F Rothé, JF Laes, D Lambrechts, D Smeets, D Vincent, M Maetens, ...
Annals of oncology 25 (10), 1959-1965, 2014
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis
M Ignatiadis, SK Singhal, C Desmedt, B Haibe-Kains, C Criscitiello, ...
Journal of clinical oncology 30 (16), 1996-2004, 2012
HER2-positive circulating tumor cells in breast cancer
M Ignatiadis, F Rothe, C Chaboteaux, V Durbecq, G Rouas, C Criscitiello, ...
PloS one 6 (1), e15624, 2011
Luminal breast cancer: from biology to treatment
M Ignatiadis, C Sotiriou
Nature reviews Clinical oncology 10 (9), 494-506, 2013
The system can't perform the operation now. Try again later.
Articles 1–20